The initiative aims to identify important assets critical to improving human health and to cultivate the next generation of pharmaceutical industry business leaders. Future Labs is part of Apimeds’ ...

David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...

T he biotech and pharmaceutical sectors stand at the brink of innovation and strategic transformation. Market momentum continues to build, with the global biotechnology market valued at around $2 ...

Filippo Mulinacci joined Araris Biotech in 2022 as its chief business officer. In March, the oncology company, based in Zurich, Switzerland, was acquired by Taiho Pharma, based in Tokyo, as part of a ...

MATAWAN, N.J.--(BUSINESS WIRE)-- Apimeds Pharmaceuticals US, Inc. (APUS) (“Apimeds”) today announced the expansion of its ai² Future Labs program by engaging graduate students from the University of ...

In the fast-paced world of biotechnology, success hinges on more than groundbreaking science—it requires the right connections, strategic partnerships, and access to capital. Biotech Showcase delivers ...

Alchemab Therapeutics has appointed Ulrich Wendt, PhD MBA, as Chief Business Officer (CBO) to expand partnerships with ...

Damian Garde joins Allison, Adam, and Elaine to discuss his article about Boris Nikolic, a well-connected biotech investor ...

Aurion Biotech today named Dr. Marjan Farid, Director of Cornea, Cataract, and Refractive Surgery and a Clinical Professor at ...

MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the launch of its ai² Future Labs program in partnership with The University of ...

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced ...